indomethacin
inhibitor
wide
use
clinic
potent
antiinflammatoryanalges
properti
possess
antivir
activ
sever
viral
pathogen
howev
mechan
antivir
action
remain
elus
recent
shown
indomethacin
activ
doublestrand
rna
dsrna
depend
protein
kinas
r
pkr
human
colon
cancer
cell
import
role
pkr
cellular
defenc
respons
viral
infect
herein
investig
effect
indomethacin
pkr
activ
infect
prototyp
rhabdoviru
vesicular
stomat
viru
indomethacin
found
activ
pkr
interferonand
dsrnaindepend
manner
caus
rapid
min
phosphoryl
eukaryot
initi
event
result
shut
viral
protein
translat
block
viral
replic
ic
protect
host
cell
virusinduc
damag
indomethacin
affect
kinas
pkrlike
endoplasm
reticulumresid
protein
kinas
perk
gener
control
kinas
unabl
trigger
phosphoryl
presenc
pkr
inhibitor
addit
smallinterf
rnamedi
pkr
gene
silenc
dampen
antivir
effect
indomethacintr
cell
result
identifi
pkr
critic
target
antivir
activ
indomethacin
indic
phosphoryl
could
key
element
broad
spectrum
antivir
activ
drug
doublestrand
rna
dsrna
depend
protein
kinas
pkr
interferoninduc
serin
threonin
protein
kinas
play
essenti
role
innat
immun
respons
viral
infect
act
sensor
viru
replic
et
al
dabo
meur
pkr
encod
singl
gene
locat
human
chromosom
contain
ctermin
kinas
domain
kd
share
three
mammalian
kinas
pkrlike
endoplasm
reticulumresid
protein
kinas
perk
pek
hemeregul
inhibitor
kinas
hri
homologu
saccharomyc
cerevisia
gener
control
kinas
phosphoryl
eukaryot
initi
factor
respons
stress
signal
schneider
mohr
baltzi
et
al
holcik
sonenberg
taylor
et
al
multiprotein
complex
respons
recruit
initi
mettrna
met
ribosom
subunit
guanosin
triphosph
gtp
depend
manner
clemen
gebauer
hentz
holcik
sonenberg
phosphoryl
residu
function
domin
inhibitor
guanin
exchang
factor
prevent
recycl
gtp
requir
ongo
translat
thu
lead
gener
inhibit
protein
synthesi
clemen
taylor
et
al
addit
kd
share
kinas
pkr
also
contain
ntermin
dsrnabind
domain
dsrbd
consist
two
dsrnabind
motif
amino
acid
connect
short
linker
regul
activ
uninfect
nonstress
cell
pkr
found
monomer
latent
state
due
autoinhibitori
effect
dsrbd
normal
occlud
kd
et
al
upon
bind
dsrna
produc
viru
replic
intermedi
pkr
undergo
homodimer
autophosphoryl
lead
substrat
dock
phosphoryl
block
protein
synthesi
viral
infect
cell
taylor
et
al
dabo
meur
dsrnainduc
pkrmediat
phosphoryl
repres
primari
antivir
respons
mammalian
cell
schneider
mohr
et
al
fact
product
dsrna
oblig
part
genom
replic
cycl
rna
virus
rna
serv
templat
viral
transcript
replic
dsrna
often
produc
oppos
transcript
unit
also
dna
viru
replic
schneider
mohr
addit
role
translat
pkr
particip
sever
signal
pathway
control
transcript
includ
kinas
ikk
nuclear
pathway
santoro
et
al
et
al
dabo
meur
implic
control
cell
growth
differenti
apoptosi
gener
tumour
suppress
function
et
al
et
al
prototyp
rhabdoviru
vesicular
stomat
viru
vsv
negativesens
singlestrand
rna
viru
wide
studi
model
viral
protein
translat
control
lyle
et
al
follow
viral
penetr
uncoat
vsv
primari
mrna
synthes
host
cell
cytoplasm
virusassoci
rnadepend
rna
polymeras
rdrp
viral
protein
begin
accumul
progeni
viral
genom
replic
use
secondari
transcript
mrna
primari
secondari
transcript
similar
structur
host
messeng
contain
cap
tail
similar
length
host
mrna
connor
lyle
lyle
et
al
vsv
replic
host
translat
rapidli
inhibit
event
mainli
attribut
virusinduc
modif
host
eukaryot
initi
enhanc
translat
effici
viral
mrna
dampen
synthesi
host
protein
includ
antivir
defenc
enzym
connor
lyle
previou
studi
suggest
nonsteroid
antiinflammatori
drug
indomethacin
indo
inhibit
vsv
replic
possibl
affect
transcript
viral
messag
mukherje
simpson
indo
tradit
inhibitor
wide
use
clinic
potent
antiinflammatori
analges
properti
vane
bot
addit
antiinflammatoryanalges
action
indomethacin
known
sever
decad
also
possess
antivir
properti
sinc
initi
discoveri
inglot
vitro
vivo
studi
confirm
antivir
activ
indomethacin
sever
human
viral
pathogen
includ
herp
viru
zhu
et
al
rotaviru
rossen
et
al
hepat
b
bahrami
et
al
human
immunodefici
viru
hiv
ramirez
et
al
bourinbaiar
leehuang
sarscov
coronaviru
agent
sever
acut
respiratori
syndrom
amici
et
al
experiment
clinic
evid
accumul
suggest
novel
therapeut
use
classic
antiinflammatori
drug
viral
infect
howev
lack
understand
mechan
antivir
action
major
drawback
indo
treatment
viral
diseas
indomethacin
abil
inhibit
replic
sever
unrel
dna
rna
virus
point
hostmedi
antivir
mechan
rather
effect
virusspecif
enzym
howev
mechan
remain
larg
unknown
previous
observ
indo
caus
dysregul
protein
synthesi
coronavirusinfect
cell
amici
et
al
herein
investig
molecular
mechan
respons
antivir
activ
indo
vsv
infect
demonstr
indo
act
translat
level
rapidli
induc
phosphoryl
phosphoryl
occur
concentr
indo
c
max
rang
detect
patient
treat
mediumhigh
dose
drug
benet
confirm
previou
observ
cancer
cell
brunelli
et
al
phosphoryl
found
mediat
select
activ
pkr
interestingli
sipkr
silenc
dampen
abil
indo
inhibit
vsv
protein
synthesi
identifi
pkr
key
element
antivir
activ
drug
investig
effect
indomethacin
vsv
replic
epitheli
monkey
cell
mock
infect
infect
vsv
plaqueform
unit
pfu
per
cell
treat
differ
concentr
indo
h
adsorpt
period
viru
yield
determin
tcid
infect
assay
h
postinfect
pi
effect
indo
cell
viabil
determin
mtt
assay
mockinfect
cell
h
treatment
indo
show
remark
antivir
activ
vsv
reduc
viru
yield
dose
depend
fig
similar
condit
indo
equal
activ
differ
type
host
cell
includ
hamster
cell
human
hela
cell
supplementari
fig
vsv
infect
gener
character
massiv
cytopath
effect
caus
cell
shrinkag
loss
adhes
fig
indomethacin
treatment
addit
inhibit
viru
progeni
product
also
found
protect
cell
virusinduc
damag
strikingli
cell
treat
indo
viral
adsorpt
show
sign
infect
h
pi
fig
concentr
also
found
affect
cell
prolifer
least
h
supplementari
fig
use
follow
studi
unless
differ
specifi
indo
shown
enhanc
heat
shock
factor
activ
stress
condit
promot
express
cytoprotect
heat
shock
protein
hsp
amici
et
al
cotto
et
al
associ
establish
antivir
state
cell
infect
vsv
virus
santoro
morimoto
santoro
investig
whether
indomethacin
could
act
induc
cytoprotect
heat
shock
respons
host
cell
indo
found
affect
either
dnabind
activ
accumul
kda
hsp
mockinfect
vsvinfect
cell
supplementari
fig
exclud
involv
defenc
mechan
druginduc
cytoprotect
indo
wellknown
cox
inhibitor
vane
bot
investig
effect
differ
inhibitor
vsv
infect
mockinfect
vsvinfect
pfu
per
cell
cell
treat
differ
concentr
aspirin
sodium
salicyl
inhibitor
inhibitor
h
adsorpt
period
viru
yield
determin
tcid
infect
assay
h
pi
parallel
effect
drug
cell
viabil
determin
mtt
assay
mockinfect
cell
h
treatment
result
shown
supplementari
fig
demonstr
none
nsaid
test
abl
mimic
antivir
activ
indo
concentr
near
cytotox
rang
suggest
cyclooxygenaseindepend
mechan
fact
remark
antivir
activ
vsv
could
obtain
indo
treatment
start
viru
adsorpt
indic
nsaid
affect
viru
adsorpt
entri
host
cell
addit
pretreat
cell
indo
h
period
modestli
affect
vsv
replic
drug
remov
viral
infect
supplementari
fig
effect
indomethacin
vsv
protein
synthesi
local
analys
first
set
experi
mockinfect
vsvinfect
pfu
per
cell
cell
treat
indo
h
adsorpt
period
h
pi
viral
protein
visual
immunofluoresc
microscopi
use
antivsv
antibodi
shown
fig
express
high
level
cytoplasm
viral
protein
h
pi
accompani
nearli
complet
disassembl
tubulin
filament
cytoplasm
infect
cell
viral
protein
instead
bare
detect
indotr
cell
indistinguish
uninfect
control
size
cytoskelet
arrang
investig
effect
indo
cellular
viral
protein
synthesi
mockinfect
vsvinfect
cell
treat
indo
viru
adsorpt
label
methionin
h
pi
next
h
sampl
contain
equal
amount
pro
tein
equal
amount
radioact
process
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
autoradiographi
shown
fig
indo
treatment
strongli
inhibit
vsv
protein
express
prevent
virusinduc
shutoff
cellular
protein
synthesi
next
effect
indo
kinet
vsv
protein
synthesi
analys
mockinfect
vsvinfect
cell
treat
indo
viru
adsorpt
label
methionin
h
puls
differ
time
pi
indomethacin
found
caus
transient
h
inhibit
methionin
incorpor
protein
mockinfect
vsvinfect
cell
fig
sampl
contain
amount
radioact
process
sdspage
autoradiographi
densitometr
analysi
shown
fig
accumul
vsv
protein
evid
start
h
pi
wherea
shutoff
host
cell
protein
synthesi
observ
later
time
h
pi
infect
cell
indo
treatment
confirm
strongli
inhibit
vsv
protein
express
prevent
virusinduc
shutoff
cellular
protein
synthesi
h
pi
fig
point
synthesi
vsv
protein
particular
n
protein
could
detect
start
h
pi
indotr
cell
investig
whether
inhibit
viral
protein
express
depend
transcript
activ
host
antivir
protein
indo
cell
mrna
transcript
block
actinomycind
amd
inhibitor
cellular
viral
rna
polymeras
mukherje
simpson
mockinfect
vsvinfect
cell
treat
indo
presenc
absenc
amd
ml
adsorpt
period
label
methionin
h
puls
h
pi
parallel
sampl
rna
synthesi
analys
h
uridin
label
viru
yield
determin
h
pi
shown
fig
panel
b
amd
treatment
inhibit
cellular
rna
synthesi
h
uridin
incorpor
uninfect
control
uninfect
amd
vsvinfect
control
fig
effect
indomethacin
vsv
protein
express
intracellular
local
cell
mock
infect
infect
vsv
pfu
per
cell
treat
indo
h
adsorpt
period
h
pi
viral
protein
visual
immunofluoresc
microscopi
use
antivsv
green
red
antibodi
nuclei
stain
dapi
blue
overlay
three
fluorochrom
shown
merg
imag
collect
deconvolv
deltavis
microscop
softwar
bar
vsvinfect
amd
cpm
cell
dampen
indomedi
antivir
effect
suggest
differ
interferon
host
defenc
protein
express
requir
antivir
activ
indomethacin
previous
suggest
inhibit
vsv
mrna
transcript
mukherje
simpson
establish
whether
indo
affect
viru
protein
express
transcript
translat
level
total
viral
rna
primari
transcript
level
determin
northern
blot
analysi
infect
cell
h
pi
viral
primari
transcript
accumul
obtain
block
viral
protein
synthesi
essenti
viral
replic
amplif
viral
secondari
transcript
cycloheximid
treatment
ml
start
min
prior
viral
infect
fact
indo
significantli
affect
vsv
primari
transcript
wherea
dramat
reduc
vsv
total
rna
level
fig
suggest
effect
viral
mrna
translat
translat
block
fact
demonstr
polysom
profil
analysi
cell
extract
sucros
gradient
fraction
shown
fig
indo
caus
rapid
substanti
decreas
heavier
polysom
characterist
reduc
rate
translat
initi
mockinfect
vsvinfect
cell
min
pi
indic
earlier
translat
inhibit
transient
demonstr
protein
synthesi
recoveri
later
time
treatment
fig
translat
control
primarili
mediat
level
initi
gebauer
hentz
holcik
sonenberg
particular
phosphoryl
translat
initi
factor
potent
mechan
translat
control
clemen
taylor
et
al
effect
indo
phosphoryl
investig
cell
mockinfect
vsvinfect
cell
treat
differ
concentr
indo
level
determin
min
shown
fig
indo
found
potent
induc
phosphoryl
start
concentr
low
micromolar
rang
mockinfect
cell
vsvinfect
cell
indo
treatment
induc
phosphoryl
concentr
concomitantli
substanti
decreas
viral
yield
see
fig
phosphoryl
rapid
event
start
soon
min
drug
administr
attenu
h
treatment
fig
concomitantli
releas
protein
synthesi
inhibit
see
fig
high
cytoplasm
level
also
visual
min
indo
treatment
immunofluoresc
fig
indomethacininduc
phosphoryl
requir
protein
express
shown
high
level
indo
min
label
green
red
antibodi
nuclei
stain
dapi
blue
bar
overlay
three
fluorochrom
shown
merg
microscopi
perform
leica
dmil
microscop
equip
uv
excit
filter
imag
captur
leica
camera
use
leica
imagemanag
softwar
cell
pretreat
min
control
vehicl
c
ml
cycloheximid
chx
inhibit
methionin
incorpor
protein
ml
amd
inhibit
h
uridin
incorpor
acidinsolubl
materi
treat
indo
vehicl
min
lysat
analys
western
blot
use
panspecif
antibodi
top
panel
graph
show
ratio
sampl
bottom
panel
valu
repres
mean
sd
two
experi
p
versu
untreat
control
e
mockinfect
vsvinfect
cell
treat
indo
adsorpt
period
h
pi
analys
western
blot
top
panel
parallel
viru
yield
determin
infect
assay
h
pi
bottom
panel
data
repres
mean
sd
duplic
sampl
repres
experi
two
similar
result
p
cell
rna
transcript
translat
block
amd
cycloheximid
treatment
respect
fig
final
phosphoryl
follow
indo
treatment
limit
cell
similar
result
obtain
uninfect
vsvinfect
cell
fig
hela
cell
brunelli
et
al
indic
introduct
section
four
distinct
eukaryot
kinas
identifi
date
dsrnaactiv
protein
kinas
pkr
perk
hri
kinas
schneider
mohr
baltzi
et
al
holcik
sonenberg
taylor
et
al
recent
shown
indo
treatment
select
activ
pkr
cyclooxygenaseindepend
manner
human
colon
cancer
cell
brunelli
et
al
confirm
pkr
kinas
respons
indoinduc
phosphoryl
also
cell
perk
hri
pkr
kinas
activ
analys
wholecel
lysat
vitro
kinas
assay
use
recombin
substrat
immunoprecipit
specif
antibodi
hri
detect
cell
indo
affect
perk
activ
wherea
strongli
induc
pkr
activ
fig
indomethacininduc
pkr
activ
also
evidenc
cell
increas
pkr
autophosphoryl
fig
start
rapidli
drug
administr
attenu
h
treatment
concomitantli
attenu
fig
shown
fig
treatment
pkr
inhibitor
result
prevent
phosphoryl
indotr
cell
confirm
pkr
respons
indoinduc
phosphoryl
cell
interestingli
treatment
also
caus
attenu
indo
antivir
activ
vsvinfect
cell
fig
investig
whether
signal
respons
vsv
translat
block
induc
indo
pkr
downregul
smallinterf
rna
si
rnamedi
silenc
cell
found
poorli
transfect
hela
cell
util
transfect
experi
hela
cell
transient
transfect
pkr
sirna
nonspecif
sirna
h
mock
infect
infect
vsv
treat
indo
h
adsorpt
period
h
pi
wholecel
extract
analys
endogen
pkr
level
vsvg
protein
level
immunoblot
analysi
mapk
tubulin
level
determin
control
shown
fig
pkr
level
greatli
reduc
pkr
sirna
transfect
cell
wherea
mapk
level
alter
expect
treatment
indo
result
nearli
complet
inhibit
vsvg
protein
synthesi
howev
pkrsilenc
cell
abil
drug
inhibit
vsv
protein
synthesi
greatli
impair
g
protein
level
approxim
four
time
higher
mocksilenc
cell
parallel
experi
hela
cell
transfect
pkr
sirna
nonspecif
sirna
infect
vsv
treat
differ
concentr
indo
h
adsorpt
period
viru
yield
determin
h
pi
shown
fig
vsv
titr
significantli
higher
pkrsilenc
cell
compar
control
confirm
pkr
particip
antivir
activ
indo
howev
pkr
silenc
partial
restor
viru
replic
treat
cell
could
consequ
residu
pkr
activ
due
partial
silenc
kinas
altern
mechan
may
contribut
antivir
activ
drug
point
previous
report
baltzi
et
al
neznanov
et
al
treatment
perk
induc
thapsigargin
minor
extent
kinas
induc
effect
reduc
vsvg
protein
level
cell
supplementari
fig
reinforc
role
phosphoryl
inhibit
vsv
protein
synthesi
final
antivir
activ
indo
investig
mous
embryon
fibroblast
mef
wild
type
knockout
perk
previous
report
baltzi
et
al
berlanga
et
al
krishnamoorthi
et
al
perk
cell
found
suscept
perk
cell
vsvinduc
cytopath
effect
cell
death
approxim
higher
knockout
wildtyp
cell
determin
mtt
assay
h
infect
vsv
pfu
per
cell
shown
supplementari
fig
indo
equal
effect
inhibit
vsv
replic
perk
perk
cell
well
cell
emphas
import
role
pkr
antivir
activ
indo
indic
introduct
section
pkr
play
critic
role
antivir
defenc
mechan
host
act
sensor
viru
replic
gil
et
al
et
al
upon
activ
lead
phosphoryl
block
protein
synthesi
viral
infect
cell
taylor
et
al
dabo
meur
recent
shown
antiinflammatori
drug
indomethacin
abl
activ
pkr
caus
rapid
phosphoryl
human
colon
carcinoma
cell
brunelli
et
al
import
role
pkr
cellular
defenc
respons
viral
infect
investig
effect
indomethacin
pkr
activ
phosphoryl
viral
infect
cell
use
rhabdoviru
vsv
model
cell
demonstr
indomethacin
activ
pkr
caus
rapid
transient
phosphoryl
similar
kinet
uninfect
vsvinfect
cell
previous
report
cancer
cell
brunelli
et
al
indomethacininduc
phosphoryl
mediat
pkr
prevent
pkr
inhibitor
addit
indo
select
activ
pkr
wherea
affect
activ
kinas
perk
cell
uninfect
cell
pkrmediat
result
transient
inhibit
protein
synthesi
hand
vsvinfect
cell
phosphoryl
earli
time
infect
result
shut
viral
protein
translat
caus
dramat
inhibit
viral
replic
infecti
viral
particl
product
treatment
pkr
silenc
result
attenu
indo
antivir
activ
vsvinfect
cell
result
consist
previou
report
show
pkr
play
essenti
role
vsv
infect
vitro
vivo
stojdl
et
al
durbin
et
al
inactiv
complex
earli
infect
block
vsv
protein
synthesi
connor
lyle
hand
krishnamoorthi
et
al
report
signific
differ
vsv
replic
detect
mef
contain
serin
alanin
mutat
compar
wildtyp
cell
indic
phosphoryl
affect
vsv
replic
normal
nonstimul
condit
nevertheless
kd
kinas
shown
necessari
suffici
inhibit
vsv
protein
express
viru
replic
human
fibrosarcoma
cell
krishnamoorthi
et
al
point
previous
report
connor
lyle
kinet
phosphoryl
may
import
control
vsv
replic
suggest
inhibit
vsv
protein
synthesi
achiev
complex
inactiv
earli
infect
fact
model
pretreat
host
cell
indo
h
period
viral
infect
time
phosphoryl
restor
basal
level
modestli
affect
vsv
replic
compar
treatment
drug
start
h
adsorpt
period
interestingli
differ
interferon
phosphoryl
follow
indo
treatment
requir
host
defenc
protein
express
fact
treatment
amd
inhibitor
cellular
viral
rna
transcript
affect
indomedi
phosphoryl
antivir
effect
addit
inhibit
infecti
viral
particl
product
emphas
indomethacin
treatment
also
protect
host
cell
virusinduc
damag
strikingli
cell
treat
indo
viral
adsorpt
show
sign
infect
cell
shrinkag
loss
adhes
h
pi
particular
indo
treatment
prevent
virusinduc
massiv
disassembl
host
microtubular
network
effect
associ
previous
describ
abil
indo
promot
cytoprotect
heat
shock
respons
enhanc
activ
hsp
express
stress
condit
amici
et
al
cotto
et
al
fact
could
detect
activ
increas
accumul
major
protein
either
uninfect
vsvinfect
cell
presenc
drug
anticip
introduct
section
larg
amount
literatur
describ
vitro
vivo
antivir
activ
indomethacin
sever
highli
pathogen
human
virus
includ
herp
viru
rotaviru
hepat
b
hiv
sarscov
coronaviru
ramirez
et
al
bourinbaiar
leehuang
zhu
et
al
rossen
et
al
bahrami
et
al
amici
et
al
despit
extens
amount
studi
mechan
wide
spectrum
activ
remain
elus
sever
decad
point
indomethacin
antivir
activ
previous
attribut
cyclooxygenas
inhibit
prostaglandin
product
herp
viru
zhu
et
al
shenk
rotaviru
rossen
et
al
infect
addit
antivir
activ
nonselect
well
select
inhibitor
report
also
vivo
sever
virus
includ
vsv
symensma
et
al
experiment
model
howev
indo
activ
mimick
nsaid
aspirin
sodium
salicyl
select
inhibitor
inhibitor
concentr
near
cytotox
rang
suggest
cyclooxygenaseindepend
mechan
result
describ
herein
demonstr
indomethacin
instead
trigger
cellular
antivir
defenc
mechan
rapidli
effect
activ
pkr
interferonand
dsrnaindepend
manner
indotrigg
pkr
signal
effect
block
viral
replic
prevent
viral
protein
translat
fact
high
level
phosphoryl
associ
indo
antivir
activ
also
infect
parainfluenza
sendai
viru
rotaviru
santoro
et
al
unpublish
result
suggest
activ
pkr
signal
cascad
may
implic
antivir
effect
indo
type
rna
virus
find
indomedi
inhibit
viral
replic
suppress
pkrsilenc
cell
perk
cell
identifi
pkr
central
player
antivir
activ
drug
howev
fact
pkr
silenc
partial
restor
viru
replic
indotr
cell
indic
mechan
may
contribut
antivir
activ
drug
moreov
addit
role
translat
pkr
particip
sever
signal
pathway
control
transcript
santoro
et
al
et
al
et
al
dabo
meur
exclud
pkrmediat
mechan
may
involv
control
vsv
replic
indo
treatment
mechan
indo
trigger
pkr
activ
remain
establish
previous
shown
indomedi
pkr
induct
cox
independ
intriguingli
indomethacin
abl
stimul
pkr
activ
absenc
natur
dsrna
induc
requir
presenc
interferon
brunelli
et
al
confirm
differ
model
addit
previous
shown
indomethacin
abl
induc
pkr
activ
vitro
level
compar
pkr
induc
poli
poli
c
suggest
direct
effect
drug
kinas
activ
brunelli
et
al
altogeth
result
suggest
pkrmediat
phosphoryl
may
key
element
broad
spectrum
antivir
activ
indomethacin
epitheli
monkey
kidney
cell
babi
hamster
kidney
cell
human
cervic
adenocarcinoma
hela
embryo
kidney
cell
perk
wildtyp
mef
scheuner
et
al
kindli
suppli
dr
randal
kaufman
cultur
either
mem
dulbecco
modifi
eagl
medium
hela
perk
perk
medium
invitrogen
supplement
fetal
calf
serum
mm
glutamin
antibiot
cell
number
evalu
standard
procedur
cell
viabil
determin
trypan
blue
exclus
assay
bromid
mtt
mtt
formazan
convers
assay
amici
et
al
indomethacin
aspirin
inhibitor
inhibitor
sigmaaldrich
dissolv
ethanol
sodium
salicyl
thapsigargin
sigmaaldrich
dissolv
dimethyl
sulfoxid
dmso
equal
amount
control
vehicl
ad
immedi
h
adsorpt
period
maintain
experi
ethanol
dmso
vehicl
effect
vsv
replic
phosphoryl
pkr
activ
concentr
test
pkr
silenc
hela
cell
transient
transfect
bp
sirna
heterogen
mixtur
nm
new
england
biolab
use
transfect
reagent
new
england
biolab
accord
manufactur
instruct
confluent
monolay
hela
cell
perk
wildtyp
mef
infect
vsv
indiana
serotyp
orsay
pfu
per
cell
h
adsorpt
period
viral
inoculum
remov
cell
monolay
wash
three
time
phosphatebuff
salin
pb
incub
condit
medium
microscop
examin
virusinduc
cytopath
effect
perform
h
pi
use
leica
dmil
leica
microsystem
gmbh
invert
microscop
imag
captur
leica
camera
use
leica
imagemanag
softwar
viru
yield
determin
tcid
tissu
cultur
infect
dose
infect
assay
describ
previous
rossi
et
al
inhibitori
concentr
lethal
dose
calcul
use
prism
softwar
graphpad
softwar
inc
cell
label
l
methionin
cell
h
puls
unless
differ
specifi
lysi
lbuffer
mm
triscl
ph
nacl
mm
sd
sampl
contain
amount
radioact
separ
sdspage
stack
gel
resolv
gel
process
autoradiographi
densitometr
analysi
rossi
et
al
analysi
polysom
profil
cell
lyse
pl
buffer
mm
nacl
mm
mm
trishcl
ph
triton
sodium
deoxychol
u
rnase
inhibitor
promega
corpor
mm
dithiothreitol
dtt
incub
ice
min
extract
centrifug
min
cold
centrifug
supernat
load
onto
linear
sucros
gradient
contain
mm
trishcl
ph
mm
nacl
mm
centrifug
beckman
sw
rotor
beckman
coulter
inc
h
rpm
profil
obtain
monitor
absorb
nm
rna
synthesi
analysi
cell
label
h
uridin
cell
h
puls
start
h
pi
radioact
incorpor
acidinsolubl
materi
determin
previous
describ
amici
et
al
cell
lyse
cold
highsalt
extract
hsb
buffer
rossi
et
al
contain
mm
dtt
mm
phenylmethanesulphonylfluorid
mm
orthovanad
mm
mm
pnpp
sigmaaldrich
proteas
inhibitor
cocktail
complet
mini
roch
wholecel
extract
separ
sdspage
blot
nitrocellulos
filter
incub
follow
antibodi
rabbit
calbiochem
merck
kgaa
antiphosphopkr
antihri
antiperk
santa
cruz
biotechnolog
inc
map
kinas
cell
signal
technolog
inc
monoclon
antipkr
santa
cruz
biotechnolog
stressgen
sigmaaldrich
antibodi
polyclon
antivsvg
antibodi
kind
gift
e
rodriguezboulan
cornel
univers
new
york
decor
peroxidaselabel
antimous
antirabbit
igg
ecl
amersham
bioscienc
quantit
evalu
protein
determin
typhoon
imag
ge
healthcar
use
imagequ
softwar
brunelli
et
al
immunoprecipit
kinas
assay
pkr
kinas
assay
describ
previous
brunelli
et
al
briefli
protein
extract
subject
immunoprecipit
use
antipkr
perk
hri
antibodi
presenc
protein
asepharos
h
extens
wash
hsb
buffer
immun
complex
resuspend
kinas
buffer
mm
trishcl
ph
mm
mm
mg
oac
mm
atp
contain
mm
dtt
assay
abil
phosphoryl
recombin
cell
scienc
min
incub
termin
addit
sd
sampl
buffer
phosphoryl
detect
western
blot
analysi
use
rabbit
antibodi
calbiochem
total
kinas
level
determin
immunoblot
sampl
load
control
detect
pkr
autophosphoryl
wholecel
extract
cell
treat
indo
control
vehicl
analys
western
blot
use
antiphosphopkr
antibodi
antipkr
antibodi
load
control
total
rna
uninfect
virusinfect
cell
isol
use
trizol
invitrogen
accord
manufactur
specif
store
detect
vsv
mrna
aliquot
total
rna
fraction
agaros
formaldehyd
gel
transfer
onto
hybondn
nylon
membran
amersham
bioscienc
ge
healthcar
hybrid
p
label
plasmid
gallion
et
al
strip
filter
rehybrid
plasmid
specif
gene
endlabel
kinas
p
atp
amersham
bioscienc
load
control
amici
et
al
rna
quantifi
molecular
dynam
imag
ge
healthcar
use
imagequ
amershamg
healthcar
softwar
molecular
dynam
analysi
mda
cell
grown
coverslip
fix
paraformaldehyd
permeabil
triton
pb
nuclear
stain
sigmaaldrich
cell
incub
polyclon
antivsv
antibodi
monoclon
antibodi
wash
cell
incub
fluorescein
isothiocyanateconjug
antirabbit
rhodamineconjug
antimous
antibodi
vsv
respect
imag
captur
deconvolv
deltavis
microscop
appliedprecis
llc
use
softwar
appli
precis
overlay
three
fluorochrom
shown
imag
captur
leica
dmlb
microscop
equip
uv
excit
filter
leica
camera
use
leica
softwar
aliquot
total
extract
prepar
lysi
highsalt
extract
buffer
rossi
et
al
incub
p
label
hse
dna
probe
rossi
et
al
follow
analysi
dnabind
activ
emsa
nondenatur
polyacrylamid
gel
caselli
et
al
specif
proteindna
complex
verifi
competit
unlabel
probe
supershift
polyclon
antibodi
specif
describ
rossi
et
al
quantit
evalu
hsfhse
complex
format
determin
typhoon
imag
use
imagequ
softwar
statist
analysi
perform
use
student
ttest
unpair
data
viru
titrat
experi
data
repres
mean
standard
deviat
duplic
sampl
repres
experi
three
similar
result
pvalu
consid
signific
cytomegaloviru
proc
natl
acad
sci
usa
stojdl
df
abraham
n
knowl
mariu
r
brasey
lichti
bd
et
al
murin
doublestrand
rnadepend
protein
kinas
pkr
requir
resist
vesicular
stomat
viru
j
virol
symensma
tl
martinezguzman
jia
q
bortz
e
wu
tt
rudraganguli
n
et
al
addit
support
inform
may
found
onlin
version
articl
publish
websit
fig
indomethacin
inhibit
vsv
replic
differ
type
cell
fig
effect
indo
cell
prolifer
fig
indomethacin
cytoprotect
activ
independ
host
heat
shock
respons
fig
differ
cox
inhibitor
mimic
antivir
effect
indo
fig
effect
indo
treatment
vsv
infect
fig
effect
thapsigargin
vsvg
protein
level
fig
effect
indo
vsv
replic
perk
cell
